Cargando…
Sound prescriptions to mitigate the effects of COVID-19 in the population with Down syndrome
Autores principales: | Verd, Sergio, Vinuela, Isabel, Verd, Mateo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149290/ https://www.ncbi.nlm.nih.gov/pubmed/34037877 http://dx.doi.org/10.1007/s10072-021-05315-x |
Ejemplares similares
-
Commentary: Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness?
por: Verd, Sergio, et al.
Publicado: (2021) -
COVID-19 in patients with Down syndrome
por: Emami, Amir, et al.
Publicado: (2021) -
COVID-19 infection and Down syndrome—challenges and future directions for care in children
por: Chauhan, Kaushambi, et al.
Publicado: (2022) -
Down syndrome: the aggravation of COVID-19 may be partially justified by the expression of TMPRSS2
por: Evangelho, Victor Gustavo Oliveira, et al.
Publicado: (2021) -
Down’s syndrome and COVID-19: risk or protection factor against infection? A molecular and genetic approach
por: Altable, Marcos, et al.
Publicado: (2020)